Wenbao Li

Qingdao, 266071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

The role of miRNAs as biomarkers in heterotopic ossification.

The role of miRNAs as biomarkers in heterotopic ossification.

Journal: EFORT open reviews

Published: December 02, 2024

Design, synthesis, and structure-activity relationship study of novel plinabulin derivatives as anti-tumor agents based on the co-crystal structure.

Design, synthesis, and structure-activity relationship study of novel plinabulin derivatives as anti-tumor agents based on the co-crystal structure.

Journal: Molecular diversity

Published: January 30, 2024

Design and Synthesis of Novel Phenylahistin Derivatives Based on Co-Crystal Structures as Potent Microtubule Inhibitors for Anti-Cancer Therapy.

Design and Synthesis of Novel Phenylahistin Derivatives Based on Co-Crystal Structures as Potent Microtubule Inhibitors for Anti-Cancer Therapy.

Journal: Marine drugs

Published: October 29, 2022

Conformation and energy investigation of microtubule longitudinal dynamic instability induced by natural products.

Conformation and energy investigation of microtubule longitudinal dynamic instability induced by natural products.

Journal: Chemical biology & drug design

Published: May 11, 2022

Structure-based design and synthesis of novel furan-diketopiperazine-type derivatives as potent microtubule inhibitors for treating cancer.

Structure-based design and synthesis of novel furan-diketopiperazine-type derivatives as potent microtubule inhibitors for treating cancer.

Journal: Bioorganic & medicinal chemistry

Published: January 04, 2020

Development of novel phenoxy-diketopiperazine-type plinabulin derivatives as potent antimicrotubule agents based on the co-crystal structure.

Development of novel phenoxy-diketopiperazine-type plinabulin derivatives as potent antimicrotubule agents based on the co-crystal structure.

Journal: Bioorganic & medicinal chemistry

Published: July 04, 2019

Seahorse treatment improves depression-like behavior in mice exposed to CUMS through reducing inflammation/oxidants and restoring neurotransmitter and neurotrophin function.

Seahorse treatment improves depression-like behavior in mice exposed to CUMS through reducing inflammation/oxidants and restoring neurotransmitter and neurotrophin function.

Journal: Journal of ethnopharmacology

Published: May 03, 2019

Polymorphs, co-crystal structure and pharmacodynamics study of MBRI-001, a deuterium-substituted plinabulin derivative as a tubulin polymerization inhibitor.

Polymorphs, co-crystal structure and pharmacodynamics study of MBRI-001, a deuterium-substituted plinabulin derivative as a tubulin polymerization inhibitor.

Journal: Bioorganic & medicinal chemistry

Published: January 29, 2019

Development of M10, myricetin-3-O-β-d-lactose sodium salt, a derivative of myricetin as a potent agent of anti-chronic colonic inflammation.

Development of M10, myricetin-3-O-β-d-lactose sodium salt, a derivative of myricetin as a potent agent of anti-chronic colonic inflammation.

Journal: European journal of medicinal chemistry

Published: January 10, 2019

In vitro and in vivo pharmacokinetic and pharmacodynamic study of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent.

In vitro and in vivo pharmacokinetic and pharmacodynamic study of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent.

Journal: Bioorganic & medicinal chemistry

Published: June 19, 2018

Design, synthesis and biological evaluation of anti-pancreatic cancer activity of plinabulin derivatives based on the co-crystal structure.

Design, synthesis and biological evaluation of anti-pancreatic cancer activity of plinabulin derivatives based on the co-crystal structure.

Journal: Bioorganic & medicinal chemistry

Published: January 08, 2018

Development of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent.

Development of MBRI-001, a deuterium-substituted plinabulin derivative as a potent anti-cancer agent.

Journal: Bioorganic & medicinal chemistry letters

Published: November 12, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026